03:43 AM EDT, 08/07/2025 (MT Newswires) -- Acadia Pharmaceuticals ( ACAD ) reported Q2 earnings late Wednesday of $0.16 per diluted share, down from $0.20 a year earlier.
Analysts polled by FactSet expected $0.14.
Revenue for the quarter ended June 30 was $264.6 million, compared with $242 million a year earlier.
Analysts surveyed by FactSet expected $262 million.